UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Centric Wealth Management

Centric Wealth Management lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 44.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,380 shares of the healthcare conglomerate’s stock after selling 3,479 shares during the period. Centric Wealth Management’s holdings in UnitedHealth Group were worth $2,216,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of UNH. Norges Bank acquired a new position in UnitedHealth Group during the fourth quarter valued at $6,375,744,000. Raymond James Financial Inc. acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $1,914,740,000. Amundi raised its position in UnitedHealth Group by 97.2% during the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock valued at $3,183,132,000 after acquiring an additional 2,991,470 shares in the last quarter. Proficio Capital Partners LLC boosted its position in UnitedHealth Group by 76,830.4% in the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock worth $955,388,000 after purchasing an additional 1,886,186 shares in the last quarter. Finally, Franklin Resources Inc. lifted its stake in shares of UnitedHealth Group by 10.7% in the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock valued at $4,514,178,000 after purchasing an additional 861,854 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Barclays decreased their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a report on Friday, January 10th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. KeyCorp reissued an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Piper Sandler lowered their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $524.48 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The stock has a market cap of $479.75 billion, a price-to-earnings ratio of 33.84, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The firm has a 50 day simple moving average of $509.10 and a 200-day simple moving average of $543.47. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the company posted $5.83 EPS. The company’s quarterly revenue was up 6.8% on a year-over-year basis. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.